U.S. flag

An official website of the United States government

GTR Home > Tests > Autism Spectrum Disorders 53-Gene Panel


Test name


Autism Spectrum Disorders 53-Gene Panel

Purpose of the test


This is a clinical test intended for Help: Diagnosis, Mutation Confirmation



Click Indication tab for more information.

How to order


Order URL Help: http://www.chginc.org/

Specimen source

Amniotic fluid
Chorionic villi
Cord blood
Peripheral (whole) blood


Molecular Genetics
CSequence analysis of the entire coding region
Next-Generation (NGS)/Massively parallel sequencing (MPS)
  • ion torrent

Summary of what is tested

Click Methodology tab for more information.

Clinical utility


Not provided

Clinical validity


Not provided

Test services

  • Custom Prenatal Testing

Practice guidelines

  • NCCN, 2014
    Genetic/familial high-risk assessment: breast and ovarian, version 1.2014.
  • ACMG, 2013
    Clinical genetics evaluation in identifying the etiology of autism spectrum disorders: 2013 guideline revisions.
  • ISCA, 2010
    Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies.
  • ACMG, 2008
    Statement on guidance for genetic counseling in advanced paternal age
  • ACMG, 2008
    Clinical genetics evaluation in identifying the etiology of autism spectrum disorders (See 2013 Update)
  • Retired; ACMG, 2005
    Retired. American College of Medical Genetics guideline on the cytogenetic evaluation of the individual with developmental delay or mental retardation

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.